drugset / Trial / NCT00092157

Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)

NCT00092157

Phase 3 Completed 571 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and effectiveness of two approved drugs in lowering high cholesterol when taken together, compared to taking only one of the drugs.

Timeline

Start
2002-05-01
Primary completion
2003-03-03
Completion
2003-03-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 20 mg
Subject Simvastatin Small molecule

Indications